Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Higher iron levels in hair may increase the risk of esophageal cancer.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

The free androgen index varies among women with different types of PCOS.

Lower testosterone increases heart disease risk; higher estradiol increases risk in women.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Spironolactone might lower the chance of getting rosacea.

The new tool helps measure the impact of alopecia areata on children's quality of life.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

The screening method effectively predicts psychosis, valproate use is linked to hair loss, and IDEAS is valid for assessing mental disorder disability.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Higher inflammation markers are linked to more severe alopecia areata.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Finasteride significantly reduces the risk of prostate cancer.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Hair loss patterns are linked to temperament and can help diagnose it.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The model effectively mimics radiation-induced skin damage for future research.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Insulin resistance varies among PCOS types, and simple math tools can help identify it early.

The Free Androgen Index is important for diagnosing PCOS due to its strong link with symptoms and risk factors.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Higher stress levels were found about two weeks before a heart attack.